| Tight junction modulation and its relationship to drug delivery NN Salama, ND Eddington, A Fasano Advanced drug delivery reviews 58 (1), 15-28, 2006 | 439 | 2006 |
| MDR1 haplotypes significantly minimize intracellular uptake and transcellular P‐gp substrate transport in recombinant LLC‐PK1 cells NN Salama, Z Yang, T Bui, RJY Ho Journal of pharmaceutical sciences 95 (10), 2293-2308, 2006 | 167 | 2006 |
| Enaminones: Exploring additional therapeutic activities IO Edafiogho, SB Kombian, KVV Ananthalakshmi, NN Salama, ... Journal of pharmaceutical sciences 96 (10), 2509-2531, 2007 | 121 | 2007 |
| The role of P-glycoprotein in drug resistance in multiple myeloma J Abraham, NN Salama, AK Azab Leukemia & lymphoma 56 (1), 26-33, 2015 | 109 | 2015 |
| Synthesis and anticonvulsant activity of enaminones: Part 7. Synthesis and anticonvulsant evaluation of ethyl 4-[(substituted phenyl) amino]-6-methyl-2-oxocyclohex-3-ene-1 … ND Eddington, DS Cox, M Khurana, NN Salama, JP Stables, SJ Harrison, ... European journal of medicinal chemistry 38 (1), 49-64, 2003 | 106 | 2003 |
| Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial D Adkins, J Ley, P Neupane, F Worden, AG Sacco, K Palka, ... The lancet oncology 20 (9), 1295-1305, 2019 | 99 | 2019 |
| Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis AM Vilay, M Grio, DD DePestel, KM Sowinski, L Gao, M Heung, ... Critical care medicine 39 (1), 19, 2011 | 93 | 2011 |
| Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin DS Cox, S Raje, H Gao, NN Salama, ND Eddington Pharmaceutical research 19, 1680-1688, 2002 | 85 | 2002 |
| Targeting CD47 as a novel immunotherapy for multiple myeloma J Sun, B Muz, K Alhallak, M Markovic, S Gurley, Z Wang, N Guenthner, ... Cancers 12 (2), 305, 2020 | 68 | 2020 |
| Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma P de la Puente, MJ Luderer, C Federico, A Jin, RC Gilson, C Egbulefu, ... Journal of Controlled Release 270, 158-176, 2018 | 56 | 2018 |
| The impact of ΔG on the oral bioavailability of low bioavailable therapeutic agents NN Salama, A Fasano, M Thakar, ND Eddington Journal of Pharmacology and Experimental Therapeutics 312 (1), 199-205, 2005 | 55 | 2005 |
| Effect of the biologically active fragment of zonula occludens toxin, ΔG, on the intestinal paracellular transport and oral absorption of mannitol NN Salama, A Fasano, R Lu, ND Eddington International journal of pharmaceutics 251 (1-2), 113-121, 2003 | 53 | 2003 |
| DM27, an enaminone, modifies the in vitro transport of antiviral therapeutic agents NN Salama, KR Scott, ND Eddington Biopharmaceutics & drug disposition 25 (5), 227-236, 2004 | 52 | 2004 |
| Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma C Federico, K Alhallak, J Sun, K Duncan, F Azab, GP Sudlow, ... Nature communications 11 (1), 6037, 2020 | 51 | 2020 |
| The impact of pharmacologic and genetic knockout of P-glycoprotein on nelfinavir levels in the brain and other tissues in mice NN Salama, EJ Kelly, T Bui, RJY Ho Journal of pharmaceutical sciences 94 (6), 1216-1225, 2005 | 50 | 2005 |
| The effect of ΔG on the transport and oral absorption of macromolecules NN Salama, A Fasano, M Thakar, ND Eddington Journal of pharmaceutical sciences 93 (5), 1310-1319, 2004 | 50 | 2004 |
| Injectable hydrogels for localized chemotherapy and radiotherapy in brain tumors P de la Puente, N Fettig, MJ Luderer, A Jin, S Shah, B Muz, V Kapoor, ... Journal of pharmaceutical sciences 107 (3), 922-933, 2018 | 48 | 2018 |
| Targeting E-selectin to tackle cancer using uproleselan B Muz, A Abdelghafer, M Markovic, J Yavner, A Melam, NN Salama, ... Cancers 13 (2), 335, 2021 | 44 | 2021 |
| Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysis NN Salama, JH Segal, MD Churchwell, JH Patel, L Gao, M Heung, ... Clinical Journal of the American Society of Nephrology 4 (7), 1190-1194, 2009 | 43 | 2009 |
| Single-dose daptomycin pharmacokinetics in chronic haemodialysis patients NN Salama, JH Segal, MD Churchwell, JH Patel, L Gao, M Heung, ... Nephrology dialysis transplantation 25 (4), 1279-1284, 2010 | 42 | 2010 |
